Akiva Mintz, M.D., Ph.D.
Division of Radiologic Science
Associate Professor, Radiology
Comprehensive Cancer Center
Brain Tumor Center of Excellence
aging, biotechnology, cancer/oncogenesis, drugs/therapeutic agents pharm, medical technology/devices, neurosciences/behavior, nuclear medicine, radiology imaging/nuclear medi
Academic: 336-716-4857 | Department: 336-716-2011
Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A, Delbono O. Pericytes at the intersection between tissue regeneration and pathology. Clin Sci (Lond). 2015;128(2):81-93.
Tamam M, Mintz A. Pseudoaneurysm of a pancreas allograft artery detected by 99mTc red blood cell SPECT/CT. Clin Nucl Med. 2015;40(4):e241-e244.
Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A, Delbono O. Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol. 2014;307(1):C25-C38.
Wadas TJ, Pandya DN, Solingapuram Sai KK, Mintz A. Molecular targeted alpha-particle therapy for oncologic applications. AJR Am J Roentgenol. 2014;203(2):253-260.
Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A, Delbono O. Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle. Front Aging Neurosci. 2014;6():245.
Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang ZM, Messi ML, Mintz A, Delbono O. Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther. 2014;5(6):122.
Sattiraju A, Birbrair A, Zhu D, Batista I, Delbono O, Mintz A. Therapeutic potential of a newly discovered neural like stem cell [abstract]. Neuro Oncol. 2014;16(Suppl 5):v203.
Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A, Delbono O. Skeletal muscle neural progenitor cells exhibit properties of NG2-glia. Exp Cell Res. 2013;319(1):45-63.
Birbrair A, Zhang T, Wang Z-M, Messi ML, Enikolopov GN, Mintz A, Delbono O. Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res. 2013;10(1):67-84.
Kota G, Gupta P, Mintz A. PET/CT illustration of metastatic breast cancer to the left mandibular foramen. Clin Nucl Med. 2013;38(5):385-386.
Deford-Watts LM, Mintz A, Kridel SJ. The potential of 11C-acetate PET for monitoring the fatty acid synthesis pathway in tumors. Curr Pharm Biotechnol. 2013;14(3):300-312.
Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A, Delbono O. Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev. 2013;22(16):2298-2314.
Kota G, Gupta P, Lesser GJ, Wilson JA, Mintz A. Somatostatin receptor molecular imaging for metastatic intracranial hemangiopericytoma. Clin Nucl Med. 2013;38(12):984-987.
Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A, Delbono O. Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle. Am J Physiol Cell Physiol. 2013;305(11):C1098-1113.
Linville C, Mintz A, Hampson R, Deadwyler S, Peiffer A. Changes in FDG-PET uptake during a delayed match to samplememory task [abstract]. Neuro Oncol. 2013;15(Suppl 3):95.
Nguyen V, Zhu D, Conyers JM, Debinski W, Mintz A. Therapeutic efficacy of an optimized quadruply mutated IL13-based bacterial cytotoxin in an orthotopic murine glioma model [abstract]. Cancer Res. 2013;73(8 Suppl 1):A2150.
Gupta P, Kota G, Mintz A. Evolution of a ureteric stone from the renal pelvis to the ureter on skeletal scintigraphy with CT correlation. Clin Nucl Med. 2012;37(2):188-189.
Beauchamp A, Lively MO, Mintz A, Gibo D, Wykosky J, Debinski W. EphrinA1 is released in three forms from cancer cells by matrix metalloproteases. Mol Cell Biol. 2012;32(16):3253-3264.
Nguyen V, Conyers JM, Zhu D, Gibo DM, Hantgan RR, Larson SM, Debinski W, Mintz A. A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13R alpha2 tumor-restricted biomarker. Neuro Oncol. 2012;14(10):1239-1253.
Kota G, Gupta P, Wilson J, Lesser G, Mintz A. Metastatic intracranial hemangiopericytoma: the role of octreotide and PET imaging in diagnosis, pre-treatment and follow-up evaluation [abstract]. J Nucl Med. 2011;52(Suppl 1):abstr 1065.
Gupta P, Kota G, Alavi A, Mintz A. Unilateral diffusely increased muscle uptake of F-18 FDG in a patient with hemiparesis due to stroke. Clin Nucl Med. 2011;36(12):1140-1141.
Nguyen V, Conyers JM, Zhu D, Gibo DM, Dorsey JF, Debinski W, Mintz A. IL-13R alpha2-targeted therapy escapees: biologic and therapeutic implications. Transl Oncol. 2011;4(6):390-400.
Nguyen V, Conyers JM, Mintz A. Pretargeting the masses: a means of improving and mainstreaming targeted molecular delivery? [commentary]. Cancer Biol Ther. 2010;10(8):775-779.
Kota GK, Gupta P, Conyers JM, Mintz A. Targeting angiogenesis in an age of personalized medicine [commentary]. Cancer Biol Ther. 2010;10(9):874-877.
Hammond SN, Norden AD, Drappatz J, Phuphanich S, Reardon D, Wong ET, Plotkin SR, Lesser G, Mintz A, Raizer JJ, et al. Phase II study of monthly pasireotide LAR (Som230C) for recurrent or progressive meningioma [abstract]. Neuro Oncol. 2010;12(Suppl 4):71.
Nguyen V, Murphy LT, Beauchamp AS, Hollingsworth CK, Debinski W, Mintz A. Combinatorial targeting of EphA2 and IL-13Ralpha2 GBM-restricted biomarkers [abstract]. Neuro Oncol. 2010;12(Suppl 4):97.
Dorsey JF, Mintz A, Tian X, Dowling ML, Plastaras JP, Dicker DT, Kao GD, El-Deiry WS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther. 2009;8(12):3285-3295.
Nguyen V, Mintz A. New frontiers in biomarker-targeted molecular imaging [commentary]. Cancer Biol Ther. 2009;8(23):2235-2238.
Mintz A, Gibo DM, MadhanKumar AB, Cladel NM, Christensen ND, Debinski W. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2. Cancer Biother Radiopharm. 2008;23(5):581-589.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.